Nunzio Sciammetta
25Patents
6h-index
98Co-inventors
64Inventor score
Filing activity: Jul 11, 2011 → Jun 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556168B2 | N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 16 | Active |
| US9663522B2 | 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 15 | Active |
| US9487490B2 | 3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 15 | Active |
| US9663502B2 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Chemistry; Metallurgy | 12 | Active |
| US9783511B2 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 9 | Active |
| US9809561B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 8 | Active |
| US10221146B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 6 | Active |
| US10086000B2 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Human Necessities | 3 | Active |
| US8592629B2 | Sulfonamide derivatives as Nav 1.7 inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10221142B2 | Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US10995085B2 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10508108B2 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Chemistry; Metallurgy | 1 | Active |
| US12157727B2 | Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8685977B2 | Chemical compounds | Chemistry; Metallurgy | 0 | Active |
| US11111232B2 | Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11498904B2 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11208407B2 | Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10442819B2 | Tricyclic compounds as inhibitors of mutant IDH enzymes | Human Necessities | 0 | Active |
| US11103493B2 | Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11319283B2 | Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10538497B2 | Compounds as indoleamine 2,3-dioxygenase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10647705B2 | Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10745364B2 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US12319671B2 | 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11319295B2 | Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.